Kimmel Cancer Center Director William Nelson, M.D., Ph.D., discusses the potential of breakthrough immune therapies to work against virtually every type of cancer and the key role Johns Hopkins scientists are playing in advancing these treatments.

Cancer patients share their stories of how immune therapies developed at the Kimmel Cancer Center saved their lives.

Pediatric cancer experts, Drs. Christopher Gamper and Brian Ladle, explain how they are developing immune therapies for the youngest cancer patients.

Bone marrow transplant researchers provided a unique perspective of normal immune cells, malignant ones, and the magnitude of the immune system’s power, and this understanding helped pave the way for a new era of immune therapies.

Biomedical engineer, Dr. Jennifer Elisseeff, has devised a way to boost the body’s ability to heal from trauma injuries, and now she is translating the first-of-its-kind approach into an unexpected cancer therapy.

Immune Therapy: A new kind of cancer therapy that empowers the body’s own natural defenses is here and, in some patients, provides unparalleled, long-lasting responses, even in the most advanced and treatment-resistant cancers.

Dr. Leisha Emens is conducting studies of immune therapies in breast cancer and gaining traction against the most resistant forms of the disease.

Dr. Ivan Borrello explains how he is using cancer patients’ own bone marrow cells to destroy their cancer.

Infectious disease expert Dr. Cynthia Sears, explains why the microscopic organisms living within our guts may hold clues to detecting and preventing colon cancer.

Kimmel Cancer Center Director Dr. William Nelson calls the new Skip Viragh Outpatient Cancer Building “the future of cancer care.” The new building will expand The Center’s outpatient cancer clinics, clinical research and urgent care.

The Kimmel Cancer Center’s benefactor Sidney Kimmel tells what inspired him to give his fortune away.

Michael R. Bloomberg and Sidney Kimmel, two of Johns Hopkins’ leading donors, joined forces as the founding contributors to the Bloomberg~Kimmel Institute for Cancer Immunotherapy to accelerate the development of immune therapies for patients.

After an extensive national search, leading bladder cancer researcher, Dr. David McConkey, is selected to take the helm of the Johns Hopkins Greenberg Bladder Cancer Institute, aimed at advancing bladder cancer research and treatments.

Swim Across America (SAA) Baltimore raised record funds for the Kimmel Cancer Center’s SAA Laboratory, directed by Dr. Luis Diaz. He and Dr. Dung Le used SAA support to uncover a key biomarker to identify those likely to respond to immune therapy.

Cancer survivor Greg Hamilton designed the ChemoCozy, jackets that keep patients warm but allow access for IVs and other medical devices.